Clinical improvement after extracranial venoplasty in multiple sclerosis

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 10, 2012, Pages 1302-1308

  Hubbard, David ^a,e   Ponec, Donald ^b   Gooding, Justin ^b   Saxon, Richard ^b   Sauder, Heidi ^c   Haacke, Mark ^d  

^a Hubbard Foundation   (United States)

^b North County Radiology Medical Group   (United States)

^c DataSense LLC   (United States)

^d MR Innovations   (United States)

^e Hubbard Foundation   (United States)

Author keywords

CCSVI; chronic cerebrospinal venous insufficiency; MS; MSIS 29; multiple sclerosis; Multiple Sclerosis Impact Scale 29; PPMS; primary progressive multiple sclerosis; relapsing remitting multiple sclerosis; RRMS; SD; secondary progressive multiple sclerosis; SPMS; standard deviation

Indexed keywords

ACETYLSALICYLIC ACID; BETA1A INTERFERON; CLOPIDOGREL; DABIGATRAN; ENOXAPARIN; GLATIRAMER; HEPARIN; IMMUNOGLOBULIN; INTERFERON BETA SERINE; MITOXANTRONE; NATALIZUMAB; WARFARIN;

ADULT; ANGIOPLASTY; ARTICLE; AZYGOS VEIN; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; CLINICAL ASSESSMENT TOOL; DEEP VEIN THROMBOSIS; EXTRACRANIAL VENOPLASTY; FEMALE; HUMAN; INTERNAL JUGULAR VEIN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS IMPACT SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SAFETY; STATISTICAL SIGNIFICANCE; STENT; TREATMENT OUTCOME; VEIN OCCLUSION;

ADULT; AGED; ANGIOPLASTY, BALLOON; AZYGOS VEIN; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; DISABILITY EVALUATION; FEMALE; HUMANS; JUGULAR VEINS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHLEBOGRAPHY; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SPINAL CORD; STENTS; TIME FACTORS; TREATMENT OUTCOME; VENOUS INSUFFICIENCY; YOUNG ADULT;

EID: 84866736723     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.07.010     Document Type: Article

References (42)

1. P. Zamboni, E. Menegatti, I. Bartolomei Intracranial venous haemodynamics in multiple sclerosis Curr Neurovasc Res 4 2007 252 258
2. P. Zamboni, R. Galeotti, E. Menegatti A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency J Vasc Surg 50 2009 1348 1358
3. T. Ludyga, M. Kasibudzki, P. Latacz Early results of a prospective open-label study on endovascular treatments for chronic cerebrospinal venous insufficiency in the patients with associated multiple sclerosis Przeglad Flebologiczny 19 2011 9 14
4. K. Mandato, P. Hegener, G. Siskin Safety of endovascular treatment of chronic cerebrospinal venous insufficiency: a report of 240 patients with multiple sclerosis J Vasc Interv Radiol 23 2012 55 59
5. Multiple Sclerosis Council for Clinical Practice Guidelines Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis 1998 Paralyzed Veterans of America Washington, DC
6. L.B. Krupp, N.G. LaRocca, J. Muir-Nash, A.D. Steinberg The fatigue severity scale Applications to patients with multiple sclerosis and systemic lupus erythematosus Arch Neurol 46 1989 1121 1123
7. A.M. Malagoni, R. Galeotti, E. Menegatti Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis? A longitudinal pilot study Int Angiol 29 2010 176 182
8. O. Khan, M. Filippi, M. Friedman Chronic cerebrospinal venous insufficiency and multiple sclerosis Ann Neurol 67 2010 286 290
9. Experimental multiple sclerosis vascular shunting procedure halted at Stanford Ann Neurol 67 2010 A13 A15
10. R. Rudick Is multiple sclerosis caused by venous insufficiency? Nature Rev Neurol 6 2010 472 474
11. R. Fox, A. Rae-Grant Chronic cerebrospinal venous insufficiency Have we found the cause and the cure of MS? Neurology 77 2011 1 3
12. G. Siskin, Z. Haskal, G. McLennan Development of a research agenda for evaluation of interventional therapies for chronic cerebrospinal venous insufficiency: proceeding from a multidisciplinary research consensus panel J Vasc Interv Radiol 22 2011 587 593
13. C. McGuigan, M. Hutchinson The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure J Neurol Neurosurg Psychiatry 75 2004 266 269
14. J. Joy Multiple sclerosis: current status and strategies for the future 2003 National Academic Press Washington, DC 198
15. J.C. Hobart, A. Riazi, D. Lamping How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self-report scales J Neurol Neurosurg Psychiatry 76 2005 1539 1543
16. J. Freeman, J. Hobart, D. Langdon, A. Thompson Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis J Neurol Neurosurg Psychiatry 68 2000 150 156
17. D.F. Cella, K. Dineen, B. Arnason Validation of the functional assessment of multiple sclerosis quality of life instrument Neurology 47 1996 1129 1139
18. L. Costelloe, K. O'Rourke, H. Kearney The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical) J Neurol Neurosurg Psychiatry 78 2007 841 844
19. J. Kurtzke On the evaluation of disability in multiple sclerosis Neurology 50 1998 317 321
20. E.M. Haacke, W. Feng, D. Utriainen Patients with multiple sclerosis with structural venous abnormalities on MR imaging exhibit an abnormal flow distribution of the internal jugular veins J Vasc Interv Radiol 23 2012 60 68
21. P. Behan Futility of the autoimmune orthodoxy in multiple sclerosis research Expert Rev Neurother 10 2010 1023 1025
22. A. Miller Multiple sclerosis: where will we be in 2020? Mt Sinai J Med 78 2011 268 279
23. B. Trapp, K. Nave Multiple sclerosis: an immune or neurodegenerative disorder? Ann Rev Neurosci 31 2008 247 269
24. E.M. Frohman, M.K. Racke, C.S. Raine Multiple sclerosis - the plaque and its pathogenesis N Engl J Med 354 2006 942 955
25. M. Barnett, J. Prineas Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion Ann Neurol 55 2004 458 468
26. M. Barnett, I. Sutton The pathology of multiple sclerosis: a paradigm shift Curr Opin Neurol 19 2006 242 247
27. M.H. Barnett, A. Henderson, J. Prineas The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion Mult Scler 12 2006 121 132
28. A. Henderson, M. Barnett, J. Parratt, J. Prineas Multiple sclerosis, distribution of inflammatory cells in newly forming lesions Ann Neurol 66 2009 739 753
29. J. Bergan, G. Schmid-Schonbein, P. Smith Chronic venous disease Review N Engl J Med 355 2006 488 498
30. A.V. Singh, P. Zamboni Anomalous venous blood flow and iron deposition in multiple sclerosis J Cerebr Blood Flow Metab 29 2009 1867 1878
31. C. Diaconu, S. Staugatis, J. McBride, C. Schwanger, A. Rae-Grant, R. Fox Anatomical and histological analysis of venous structures associated with chronic cerebro-spinal venous insufficiency Paper presented at: The 5th Joint Triennial Congress of the European and American Committees on Treatment and Research in Multiple Sclerosis Amsterdam, the Netherlands 2011 October 19-22
32. P. Zamboni, E. Menegatti, B. Weinstock-Guttman Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report BMC Med 9 2011 22
33. W. Rashid, L. Parkes, G. Ingle Abnormalities of cerebral perfusion in multiple sclerosis J Neurol Neurosurg Psychiatry 75 2004 1288 1293
34. M. Law, A. Saindane, Y. Ge Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter Radiology 231 2004 645 652
35. A. Varga, G. Johnson, J. Babb White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis J Neurol Sci 282 2009 28 33
36. L. Parkes, W. Rashid, D. Chard, P. Tofts Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects Magn Reson Med 51 2004 736 743
37. R. Wolfe, J. Detre Clinical neuroimaging using arterial spin-labeled perfusion MRI Neurotherapeutics 4 2007 346 359
38. E.M. Haacke, J. Tang, J. Neelevalli, Y. Cheng Susceptibility mapping as a means to visualize veins and quantify oxygen saturation J Magn Reson Imaging 32 2010 663 676
39. F. Doepp, P. Friedemann, J. Valdueza No cerebrocervical venous congestion in patients with multiple sclerosis Ann Neurol 68 2010 173 183
40. C. Baracchini, P. Perini, M. Calabrese No evidence of chronic cerebrospinal insufficiency at multiple sclerosis onset Ann Neurol 69 2011 90 99
41. R. Zivadinov, K. Marr, G. Cutter Prevalence, sensitivity, and specificity of chronic cerebrospinal insufficiency in MS Neurology 77 2011 1 7
42. US Food and Drug Administration: FDA news release May 10, 2012. FDA issues alert on potential dangers of unproven treatment for multiple sclerosis http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303538.htm Accessed June 15, 2012